Publications by authors named "Adam M Tritsch"
Article Synopsis
- - The use of biologic therapies, especially anti-TNF medications, is increasing for treating severe inflammatory bowel disease, but they can raise cancer risks.
- - This case report focuses on a 69-year-old man with Crohn's disease who developed glioblastoma multiforme (GBM) while on adalimumab, illustrating a potential rare link between the two.
- - It highlights the challenges of treating active Crohn's disease in a patient with GBM, particularly in managing flare-ups of the bowel disease.
Introduction: Fecal immunochemical testing (FIT) is the most commonly used colorectal cancer (CRC) screening tool worldwide and accounts for 10% of all CRC screening in the United States. Potential vulnerabilities for patients enrolled to facilities within the military health system have recently come to light requiring reassessment of best practices. We studied the impact of a process improvement initiative designed to improve the safety and quality of care for patients after a positive screening FIT given previously published reports of poor organization performance.
View Article and Find Full Text PDFBackground: Bariatric surgery is being performed with increasing frequency in the USA as a definitive treatment for morbid obesity and associated comorbidities. Management strategies of type 2 diabetes mellitus (T2DM) and hypertension (HTN) medications in sleeve gastrectomy (SG) patients postoperatively are unclear, specifically in the immediate postoperative period and 6 months following surgery.
Methods: From 01 June 2010 to 30 June 2011, at a single military medical facility, a retrospective review of 88 consecutive SG patients was conducted to examine the postoperative medical management of HTN and T2DM.